Application Sponsors
ANDA 065420 | WOCKHARDT BIO AG | |
Marketing Status
Application Products
001 | FOR SUSPENSION;ORAL | 600MG/5ML;EQ 42.9MG BASE/5ML | 0 | AMOXICILLIN AND CLAVULANATE POTASSIUM | AMOXICILLIN; CLAVULANATE POTASSIUM |
FDA Submissions
| ORIG | 1 | AP | 2013-12-02 | |
LABELING; Labeling | SUPPL | 2 | AP | 2016-10-10 | STANDARD |
Submissions Property Types
TE Codes
CDER Filings
WOCKHARDT BIO AG
cder:Array
(
[0] => Array
(
[ApplNo] => 65420
[companyName] => WOCKHARDT BIO AG
[docInserts] => ["",""]
[products] => [{"drugName":"AMOXICILLIN AND CLAVULANATE POTASSIUM","activeIngredients":"AMOXICILLIN; CLAVULANATE POTASSIUM","strength":"600MG\/5ML;EQ 42.9MG BASE\/5ML","dosageForm":"FOR SUSPENSION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"AMOXICILLIN AND CLAVULANATE POTASSIUM","submission":"AMOXICILLIN; CLAVULANATE POTASSIUM","actionType":"600MG\/5ML;EQ 42.9MG BASE\/5ML","submissionClassification":"FOR SUSPENSION;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)